The Success Story of Pharmeasy

Today, Pharmamasy is a reliable and well-known company, which is becoming the best platform for providing national care in India. Pharmumisy has successfully satisfied its objectives to carry out the provision of health care accessible across the country.

Pharmays simply demonstrates its customers with the most Topham products that can usually be found in medical stores and renowned pharmacies. Yes, it currently employs fewer people and has also received less funding ($10 million) than Pharmacy. The reason for Pharmacy's best performance in its industry is that the company has experienced massive growth since its inception in 2014. Year after year, the company has quadrupled its growth, which translates into the ability to round nearly 450 ₹ crores.

Founders Dharma Seth and Naval Shah have played a huge role in the growth of Pharmacy over the years. This can be evidenced by how the challenges were identified and overcome. There is no shortcut to becoming a success story. Pharmacy works as a wonderful case study to illustrate this point. What started as an unknown startup in the online pharmacy industry and grew into an established brand, Pharmacy India has overcome various obstacles on its way to success. However, the company did not achieve overnight success.

The challenges were an inevitable part of the trip from the pharmacy. By harnessing the symbiotic relationship between what the comp

 

PharmEasy IPO Date and Price Band

IPO Open	TBD
IPO Close	TBD
IPO Size:	$1 billion - $1.2 billion (estimated)
Face Value:	TBD
Price Band:	₹ to ₹ Per Share
Listing on:	BSE and NSE
Retail Portion:	20% (estimated)
Equity:	Shares

FAQs

1. Is PharmEasy listed on the stock market?

Currently PharmEasy is not publicly listed, but Investors are eyeing a listing towards the end of this year or early next year.

2. Is PharmEasy issuing IPOs?

PharmEasy’s parent company - API Holdings Ltd - plans to issue an  initial public offering (IPO) for PharmEasy in FY22 to raise up to ₹3,000 to ₹3,700 crores ($1.2 billion).

3. Is PharmEasy IPO worth buying?

According to some sources, the PharmEasy IPO is likely to value the company at around ₹21,800 crore ($3 billion). PharmEasy has also acquired its current lival Medlife. The company has shown profitable financials in the last year. Investors should consider buying into the PharmEasy IPO share price based on their own assessment of the company’s financials and record.

4. Is PharmEasy a listed company?

Currently, Pharmeasy is not a listed company. However, talks of an upcoming IPO are underway and PharmEasy IPO share price and other relevant details will be revealed soon.

5. Is PharmEasy a loss?

No. In FY 2020, PharmEasy’s losses before tax for the same period rounded off to about ₹100.7 crores while its revenue nearly doubled to ₹637 crores.

6. Is PharmEasy profitable?

Yes, PharmEasy is profitable. In its latest funding round led by Temasek, PharmEasy India raised $220 million with a final valuation of around $700 million. The company’s net worth today stands at a whopping $700 million. 

The Takeaway

Healthcare’s digitization in India has seen massive growth in the last ten years, and a chunk of this can be attributed to e-commerce platforms like PharmEasy. What started in 2014 as a shot in the dark has not become one of India’s leading startups that provides its customers with reliable and discounted healthcare. Visit PharmEasy’s website to learn more about the company. 

Looking to invest in PharmEasy’s stocks? Download the Angel Broking app to streamline your entire investing process. With the Angel Broking mobile app, you can invest anywhere at any time without any added costs. Not only is the app free to download, but your e-KYC process will take a few minutes after which you will be set to trade.

written by: